Arformoterol Tartrate Patent Expiration

Arformoterol Tartrate is Used for maintenance treatment of bronchoconstriction in patients with COPD. It was first introduced by Lupin Inc in its drug Brovana on Oct 6, 2006. 17 different companies have introduced drugs containing Arformoterol Tartrate.


Arformoterol Tartrate Patents

Given below is the list of patents protecting Arformoterol Tartrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Brovana US6472563 Formoterol tartrate process and polymorph Nov 09, 2021

(Expired)

Lupin
Brovana US6720453 Formoterol tartrate polymorph Nov 09, 2021

(Expired)

Lupin
Brovana US7145036 Formoterol tartrate polymorph Nov 09, 2021

(Expired)

Lupin
Brovana US8110706 Formoterol tartrate process and polymorph Nov 09, 2021

(Expired)

Lupin
Brovana US6667344 Bronchodilating compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US6814953 Bronchodilating compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US7348362 Bronchodilating β-agonist compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US7462645 Bronchodilating beta-agonist compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US7465756 Bronchodilating beta-agonist compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US7473710 Bronchodilating beta-agonist compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US7541385 Bronchodilating β-agonist compositions and methods Jun 22, 2021

(Expired)

Lupin
Brovana US6040344 Formoterol process Nov 12, 2016

(Expired)

Lupin
Brovana US6589508 Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol Apr 03, 2013

(Expired)

Lupin



Arformoterol Tartrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Arformoterol Tartrate Generic API Manufacturers

Several generic applications have been filed for Arformoterol Tartrate. The first generic version for Arformoterol Tartrate was by Cipla Ltd and was approved on Jun 22, 2021. And the latest generic version is by Saba Ilac Sanayi Ve Ticaret As and was approved on Apr 25, 2025.

Given below is the list of companies who have filed for Arformoterol Tartrate generic, along with the locations of their manufacturing plants worldwide.